insights_auto
Waarom is 543904 gedaald 3,39%?
Meer informatiechevron_right
543904:BOM
Mankind Pharma Ltd
₹ 2.275,00
arrow_downward
-3,39%(-79,80) 1D
16 okt, 15:50:40 GMT+5:30 · INR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor 543904 genereren…
Openen
₹ 2.354,60
Hoog
₹ 2.355,00
Laag
₹ 2.269,00
Beursw.
937,40Â mld.
Gem. vol.
40,89K
Volume
32,86K
Koers/winst-verhouding
46,03
52 wk hoog
₹ 2.640,30
52 wk laag
₹ 1.909,90
WPA
₹ 49,42
Aantal medewerkers
20K
Openen
₹ 2.354,60
Hoog
₹ 2.355,00
Laag
₹ 2.269,00
Beursw.
937,40Â mld.
Gem. vol.
40,89K
Volume
32,86K
Koers/winst-verhouding
46,03
52 wk hoog
₹ 2.640,30
52 wk laag
₹ 1.909,90
WPA
₹ 49,42
Aantal medewerkers
20K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Moneycontrol.com
·
1 dag geleden
Buzzing Stocks: Tech Mahindra surges 6% after Q2 earnings; Mankind Pharma falls 2% on Belgium acquisition
Profiel
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Over Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Medewerkers20,5K
Opgericht1991
Hoofdkantoor-
Sector-
Websitemankindpharma.com